https://www.selleckchem.com/pr....oducts/benzylpenicil
Owing to these conditions, the stored water meets the necessary conditions for discharge and provides the opportunities to use it. This phase I trial was performed to determine the maximum-tolerated dose (MTD), dose-limiting toxicities (DLTs), preliminary efficacy, and pharmacokinetics (PK) of LY01610, a novel liposome-encapsulated irinotecan, in patients with advanced esophageal squamous cell carcinoma (ESCC). This trial was conducted in two stages. In the dose-escalation stage, patients with advanced ESCC refractory